Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

951
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951
Inflammatory Response01:28

Inflammatory Response

1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MOG-Peptide Synergizes With Rapamycin to Drive CD4<sup>+</sup> T Cells Into Protective Antigen-Specific Tregs in EAE.

Immunology·2026
Same author

Clonal overlap and convergent clustering of T cell receptor signatures in Crohn's disease in monozygotic twins.

Inflammatory bowel diseases·2026
Same author

A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.

Nature immunology·2026
Same author

Movement Disorders in Aicardi-Goutières Syndrome and Response to Immunomodulation.

Annals of clinical and translational neurology·2026
Same author

TAK1 inhibition restores p53 expression and suppresses inflammation and hyperplasia in JIA synovial fibroblasts.

Rheumatology (Oxford, England)·2026
Same author

A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families.

Journal of clinical immunology·2026

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

7.2K

The 'Treg paradox' in inflammatory arthritis.

Julia T Schnell1,2, Raquel Laza Briviesca3, Taehyeung Kim3

  • 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.

Nature Reviews. Rheumatology
|December 9, 2024
PubMed
Summary

Regulatory T (Treg) cells are crucial for preventing autoimmunity but paradoxically increase in inflamed joints during arthritis. This review explores Treg cell dysfunction and heterogeneity in arthritis, offering new intervention strategies.

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.7K
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.4K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

7.2K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.7K
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.4K

Area of Science:

  • Immunology
  • Autoimmunity
  • Rheumatology

Background:

  • Regulatory T (Treg) cells, expressing CD4 and FOXP3, are vital for preventing systemic autoimmunity.
  • Increased Treg cell numbers in inflamed joints during immune-mediated arthritis present a paradox.
  • Understanding Treg cell roles in arthritis is crucial for developing effective treatments.

Purpose of the Study:

  • To explore the biology of Treg cells, focusing on their heterogeneity, function, and dysfunction in arthritis.
  • To address the 'Treg paradox' in the context of joint inflammation.
  • To propose a framework for understanding Treg cells in inflammatory arthritis and outline potential therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research on Treg cell biology in autoimmunity and arthritis.
  • Analysis of Treg cell heterogeneity, including T helper 17-like Treg cells, exTreg cells, and osteoclastogenic Treg cells.
  • Conceptual framework development for Treg cell function in inflammatory joint environments.

Main Results:

  • The inflamed environment can impair Treg cell immunosuppressive functions.
  • Specific Treg cell subsets, such as TH17-like Treg cells and exTreg cells, may contribute to tissue damage in arthritis.
  • Treg cell dysfunction, rather than a simple lack of numbers, is implicated in arthritis pathogenesis.

Conclusions:

  • A nuanced understanding of Treg cell heterogeneity and function in the context of inflammation is essential.
  • Targeting specific Treg cell subsets or their functions offers potential therapeutic avenues for inflammatory arthritis.
  • Further research into Treg cell biology can lead to novel interventions for human inflammatory arthritis.